TP53 and gastric cancer: To assess the clinicopathological significance of GNG7 in GC, the UALCAN database was searched, which revealed that the expression of GNG7 was correlated with the race, age, histological subtype, tumor grade, individual cancer stage, and TP53 mutation status of patients with GC (P < 0.05, Figure 8).